Guiyang Xintian Pharmaceutical Co Ltd (002873.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100002QB5

Price
7.70 CNY
Market cap
1.88 bn CNY
P/E (2025)
206.29
P/S (2025)
2.51
Dividend yield
0.39 %
Net margin
1.22 %
Return on equity (ROE)
0.73 %
Return on assets (ROA)
0.43 %

Guiyang Xintian Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue857.55 m CNY749.72 m CNY
Gross profit626.83 m CNY536.65 m CNY
Operating income63.20 m CNY30.12 m CNY
EBIT79.61 m CNY27.53 m CNY
Net income52.32 m CNY9.11 m CNY
Diluted EPS – continuing operations0.24 CNY0.04 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Guiyang Xintian Pharmaceutical Co Ltd

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, and blood-tonifying remedies. The company also engages in research and development; consulting; scientific research; accommodation and catering; technology promotion; pharmaceutical research and development; and health food processing activities. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in Guiyang, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.